🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

European stocks climb higher; Lagarde speech, final eurozone CPI data due

Published 11/17/2023, 03:08 PM
Updated 11/17/2023, 04:46 PM
© Reuters.
DE30
-
GC
-
LCO
-
UK100
-
CL
-
F40
-

Investing.com - European stock markets edged higher Friday, ending a volatile week on a positive note despite disappointing U.K. retail sales.

At 03:40 ET (08:40 GMT), the DAX index in Germany traded 0.6% higher, the CAC 40 in France traded up 0.7% and the FTSE 100 in the U.K. rose 0.8%.

U.K. retail sales slump

U.K. retail sales slumped 0.3% on the month in October, an annual fall of 2.7%, and U.K. consumers continued to struggle from higher interest rates and elevated inflation levels.

This was the worst month for the country's retail sector since Covid lockdowns, with sales at their lowest since February 2021, and raised concerns over the spending outlook during the vital festive quarter.

Lagarde scheduled to speak

Yet, despite these worries, the main European equity indices are set to post weekly gains as global inflation levels have tended to surprise to the downside, lifting expectations that central banks may be at peak levels for interest rates.

A sharp drop in oil prices bodes well for a further decline in headline inflation globally.

The final reading of the eurozone’s October consumer price index should confirm that trend later in the session, as the headline figure is expected to be confirmed falling to 2.9% on an annual basis, a hefty drop from 4.3% the prior month.

ECB President Christine Lagarde is set to speak at the European Banking Congress in Frankfurt later in the session, and her comments will be parsed carefully for clues of the intentions of policy makers regarding interest rates after the central bank paused its cycle of hikes last month. 

Generali slips despite profit gain

In the corporate sector, Assicurazioni Generali (BIT:GASI) stock fell 1.5% after the Italian insurer said it was sticking to its 2024 targets even after posting a hefty rise in nine-month adjusted net profit as higher premiums offset the bigger impact of claims from natural disasters.

AstraZeneca (LON:AZN) stock gained 1.6% after the U.K.-based drug maker said it had received U.S. approval for a new breast cancer treatment, while Volvo (OTC:VLVLY) Car AB (ST:VOLCARb) slumped over 10% after owner China's Geely launched a sale of 100 million shares.

 

Crude on course for weekly loss

Oil prices edged higher Friday, but were on course for the fourth straight negative week of decline amid signs of increased supplies and fears of worsening global demand. 

By 03:40 ET, the U.S. crude futures traded 0.1% higher at $72.97 a barrel, while the Brent contract climbed 0.1% to $77.50 a barrel. Both contracts are around 5% lower this week, near four-month lows.

This week’s sharp decline was mainly triggered by a steep rise in U.S. crude inventories and production sustaining at record levels.

Additionally, gold futures rose 0.1% to $1,989.25/oz, while EUR/USD traded 0.1% lower to 1.0842.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.